The Cigna Group (WBO:CIGN) Other Stockholders Equity: €-0 Mil (As of Mar. 2026)


WBO:CIGN The Cigna Group WBO:CIGN
42 GF Score
Price €251.80
! 4 Warning Signs
View Full Analysis

What is The Cigna Group Other Stockholders Equity?

The Cigna Group WBO:CIGN +0.88% 42 Other Stockholders Equity is €-0 Mil as of Mar. 2026. GuruFocus rates WBO:CIGN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

The Cigna Group's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-0 Mil.

The Cigna Group's quarterly Other Stockholders Equity stayed the same from Sep. 2025 (€0 Mil) to Dec. 2025 (€0 Mil) but then declined from Dec. 2025 (€0 Mil) to Mar. 2026 (€-0 Mil).

The Cigna Group's annual Other Stockholders Equity declined from Dec. 2023 (€0 Mil) to Dec. 2024 (€-0 Mil) but then increased from Dec. 2024 (€-0 Mil) to Dec. 2025 (€0 Mil).

The Cigna Group Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for The Cigna Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cigna Group Other Stockholders Equity Chart

The Cigna Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78,051.69 0.00 0.00 -0.00 0.00

The Cigna Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00
WBO:CIGN
42GF Score
The Cigna Group WBO:CIGN
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cigna Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0 Mil mean?
The Cigna Group (WBO:CIGN) has a Other Stockholders Equity of €-0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The Cigna Group and its competitors.
Is The Cigna Group's Other Stockholders Equity too high?
The Cigna Group's current Other Stockholders Equity is €-0 Mil. Overall, The Cigna Group has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Other Stockholders Equity compare to ELV and HUM?
The Cigna Group's Other Stockholders Equity of €-0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Plans company?
A good Other Stockholders Equity depends on the Healthcare Plans industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The Cigna Group and its competitors. The Cigna Group's current Other Stockholders Equity is €-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
The Cigna Group (WBO:CIGN) has a current Other Stockholders Equity of €-0 Mil. The current Other Stockholders Equity is €-0 Mil. The Cigna Group's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current Other Stockholders Equity is €-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
42GF Score

Get the complete analysis for WBO:CIGN

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€251.80
Price